AAAAAA
Results:
1-10
|
Results: 10
Authors:
Pontrelli, L
Dattwyler, R
Nachman, S
Citation: L. Pontrelli et al., Single-dose doxycycline for the prevention of Lyme disease, N ENG J MED, 345(18), 2001, pp. 1348-1348
Authors:
Eshleman, SH
Krogstad, P
Jackson, JB
Wang, YG
Lee, S
Wei, LJ
Cunningham, S
Wantman, M
Wiznia, A
Johnson, G
Nachman, S
Palumbo, P
Citation: Sh. Eshleman et al., Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377), J INFEC DIS, 183(12), 2001, pp. 1732-1738
Authors:
Mirochnick, M
Cooper, E
Capparelli, E
McIntosh, K
Lindsey, J
Xu, J
Jacobus, D
Mofenson, L
Bonagura, VR
Nachman, S
Yogev, R
Sullivan, JL
Spector, SA
Citation: M. Mirochnick et al., Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection, CLIN PHARM, 70(1), 2001, pp. 24-32
Authors:
Wiznia, A
Stanley, K
Krogstad, P
Johnson, G
Lee, S
McNamara, J
Moye, J
Jackson, JB
Mendez, H
Aguayo, R
Dieudonne, A
Kovacs, A
Bamji, M
Abrams, E
Rana, S
Sever, J
Nachman, S
Citation: A. Wiznia et al., Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: Week 24 results of a randomized controlled trial - PACTG 377, AIDS RES H, 16(12), 2000, pp. 1113-1121
Authors:
Borkowsky, W
Stanley, K
Douglas, SD
Lee, S
Wiznia, A
Pelton, S
Yogev, R
McIntosh, K
Nachman, S
Citation: W. Borkowsky et al., Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children, J INFEC DIS, 182(1), 2000, pp. 96-103
Authors:
King, JC
Borkowsky, W
Mahidhara, N
Madore, D
Shapiro, ED
Rutstein, RM
Tan, TQ
Farley, JJ
Dankner, WM
Nachman, S
Simoes, E
Flynn, PM
Clemens, J
Hamilton, RG
Citation: Jc. King et al., Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virus, J INFEC DIS, 181(5), 2000, pp. 1817-1821
Authors:
Philpott, S
Burger, H
Charbonneau, T
Grimson, R
Vermund, SH
Visosky, A
Nachman, S
Kovacs, A
Tropper, P
Frey, H
Weiser, B
Citation: S. Philpott et al., CCR5 genotype and resistance to vertical transmission of HIV-1, J ACQ IMM D, 21(3), 1999, pp. 189-193
Authors:
Abadi, J
Nachman, S
Kressel, AB
Pirofski, L
Citation: J. Abadi et al., Cryptococcosis in children with AIDS, CLIN INF D, 28(2), 1999, pp. 309-313
Authors:
McIntosh, K
Cooper, E
Xu, J
Mirochnick, M
Lindsey, J
Jacobus, D
Mofenson, L
Yogev, R
Spector, SA
Sullivan, JL
Sacks, H
Kovacs, A
Nachman, S
Sleasman, J
Bonagura, V
McNamara, J
Citation: K. Mcintosh et al., Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus, PEDIAT INF, 18(5), 1999, pp. 432-439
Authors:
Mirochnick, M
Cooper, E
McIntosh, K
Xu, J
Lindsey, J
Jacobus, D
Mofenson, L
Sullivan, JL
Dankner, W
Frenkel, LM
Nachman, S
Wara, DW
Johnson, D
Bonagura, VR
Rathore, MH
Cunningham, CK
McNamara, J
Citation: M. Mirochnick et al., Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children, ANTIM AG CH, 43(11), 1999, pp. 2586-2591
Risultati:
1-10
|